RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN FOR IDIOPATHIC INFLAMMATORY MYOSITIS: A MULTICENTER OBSERVATIONAL STUDY

被引：0

作者：

Palermo, A. ^{[1
]}

Bettiol, A. ^{[1
]}

Urban, M. L. ^{[1
]}

Barilaro, A. ^{[2
]}

Danieli, M. G. ^{[3
]}

Capassoni, M. ^{[4
]}

Guiducci, S. ^{[4
]}

Campochiaro, C. ^{[5
,6
]}

Dagna, L. ^{[5
,6
]}

Canti, V. ^{[7
,8
]}

Rovere-Querini, P. ^{[7
,8
]}

Cardelli, C. ^{[9
]}

Mosca, M. ^{[9
]}

Emmi, G. ^{[1
]}

机构：

[1] Univ Firenze, Dept Expt & Clin Med, Florence, Italy

[2] Careggi Univ Hosp, Neurol Unit 2, Florence, Italy

[3] Polytech Univ Marche, Dept Clin & Mol Sci, Clin Medica, Torrette Di Ancona, Italy

[4] Univ Firenze, Dept Clin & Expt Med, Rheumatol Unit, Florence, Italy

[5] IRCCS Osped San Raffaele, Milan, Italy

[6] Univ Vita Salute San Raffaele, Immunol Unit Rheumatol Allergy & Rare Dis, Milan, Italy

[7] IRCCS San Raffaele Inst, Milan, Italy

[8] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy

[9] Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, Pisa, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.4827

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0922

引用

页码：761 / 761

页数：1

共 50 条

[31] Mechanism of action and long-term tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin (IGHy) in primary immunodeficiency diseases
Sehinovych, Ihor
Melamed, Isaac
Gupta, Sudhir
Sehinovych, Ihor
Hermann, Corinna
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 288 - 289
[32] Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial
Bril, Vera
Hadden, Robert D. M.
Brannagan, Thomas H.
Bar, Michal
Chroni, Elisabeth
Rejdak, Konrad
Rivero, Alberto
Andersen, Henning
Latov, Norman
Levine, Todd
Pasnoor, Mamatha
Sacconi, Sabrina
Souayah, Nizar
Anderson-Smits, Colin
Duff, Kim
Greco, Erin
Hasan, Shabbir
Li, Zhaoyang
Yel, Leman
Ay, Hakan
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 (03) : 436 - 449
[33] Tolerability and safety of recombinant human hyaluronidase-facilitated subcutaneous infusion of human immune globulin G, 10%, in patients with primary immunodeficiencies: A study from North America
Kobayashi, R.
Stein, M.
Darter, A.
Gupta, S.
Engl, W.
Leibl, H.
Fielhauer, K.
Schiff, R. I.
ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 298 - 298
[34] TOLERABILITY AND SAFETY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF HUMAN IMMUNE GLOBULIN G, 10%, IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: A STUDY FROM NORTH AMERICA
Kobayashi, R.
Stein, M. R.
Darter, A.
Paris, K.
Gupta, S.
Testori, A.
Engl, W.
Leibl, H.
Filhauer, K.
Schiff, R. I.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A98 - A98
[35] A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults
Andras Nagy
Kimberly Duff
Alexander Bauer
Fred Okonneh
Juan Carlos Rondon
Leman Yel
Zhaoyang Li
Journal of Clinical Immunology, 2024, 44
[36] INTERIM ANALYSIS OF THE GLOBAL POST AUTHORIZATION SAFETY STUDY OF HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN 10% TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE
Rubinstein, Arye
Bridges, Tracy
McNeil, Donald
Tachdjian, Raffi
Wedner, H. James
Wasserman, Richard
Leibl, Heinz
Rabbat, Christopher
Yel, Leman
MUSCLE & NERVE, 2019, 60 : S61 - S61
[37] BUDGET IMPACT ANALYSIS OF EXPANDING USE OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IG INFUSION IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES (PID) IN BRAZIL
Mendes da Silva, B.
Regis, C.
VALUE IN HEALTH, 2021, 24 : S146 - S146
[38] Interim analysis of the global post authorization safety study of hyaluronidase-facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency disease
Rubinstein, Arye
Bridges, Tracy
McNeil, Donald
Tachdjian, Raffi
Wedner, H. James
Wasserman, Richard L.
Leibl, Heinz
Rabbat, Christopher J.
Yel, Leman
ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 357 - 357
[39] A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults
Nagy, Andras
Duff, Kimberly
Bauer, Alexander
Okonneh, Fred
Rondon, Juan Carlos
Yel, Leman
Li, Zhaoyang
JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (01)
[40] REAL-WORLD USE OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS (SC) INFUSION OF IMMUNOGLOBULIN G (IG) (IGHY; HYQVIA) IN PATIENTS (PTS) WITH PRIMARY IMMUNODEFICIENCY DISORDERS (PIDD)
Rosenbach, Kevin P.
Hughes, Stephanie M.
Rozen, Leon
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 271 - 272

← 1 2 3 4 5 →